You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
石藥集團(01093.HK):附屬開發的"注射用谷胱甘肽"獲藥監局藥品註冊批件
格隆匯 09-26 12:25

格隆匯9月26日丨石藥集團(01093.HK)公佈,集團附屬公司石藥集團歐意藥業有限公司開發的"注射用谷胱甘肽(0.3g)"已獲國家藥監局頒發藥品註冊批件。

公告顯示,谷胱甘肽為自然界廣泛存在的含巰基(SH)的三肽,在多種細胞生化功能中起作用,及參與體內三羧酸循環及糖代謝。它能促進碳水化合物、脂肪及蛋白質的代謝,並促進易代謝的低毒化合物的形成,對部分外源性毒性物質具有減毒作用。該產品可以用於化療患者(尤其是大劑量化療時)、放射治療患者、各種低氧血癥、肝臟疾病(包括病毒性和藥物毒性等引起的肝臟損害)、有機磷或硝基化合物中毒的輔助治療及解藥物毒性。

此外,注射用谷胱甘肽為集團肝臟用藥的系列產品之一,該產品的獲批完善了集團的產品綫,也為患者提供了更優質的用藥選擇。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account